日本消化器病学会アーカイブシステム

セッション	検索結果は5件です。 IF2-4-I (Keynote lecture) Image-guided percutaneous ablation therapies for hepatocellular carcinoma Shuichiro Shiina（University of TokyoTokyoJapan） Image-guided percutaneous ablation therapies have been playing important roles in the treatment of he-patocellular carcinoma （HCC）since they are potentially curativeminimally invasiveand easily re-per... 第94回日本消化器病学会総会＞ IF2-4-II (Keynote lecture) Resection and Transplantation for HCC Jacques Belghiti（Hepatobiliopancreatic and Liver Transplantation DepartmentHospital BeaujonClichyFrance） Over the past 10 yearsthere has been considerable progress in the surgical treatment of HCC including adramatic improvement of surgical resections． The high rate of recurrenceespecially in patients wi... 第94回日本消化器病学会総会＞ IF2-4-III (Keynote lecture) Molecular Targeted Therapy for Hepatocellular Carcinoma Melanie B.Thomas（The University of Texas MD Anderson Cancer CenterHoustonUSA） Until recently there has been no published evidence that systemic chemotherapy improves overall sur-vival in any subset of HCC patients． HCC are clinically chemotherapy-resistance tumoursand this obse... 第94回日本消化器病学会総会＞ IF2-4-IV (Plenary presentation) Treatment Strategy of Hepatocellular Carcinoma Ryosuke Tateishi（Department of GastroenterologyThe University of Tokyo Hospital） Current options fbr the treatment of hepatocellular carcinoma（HCC）consist of surgical resectionor－thotropic liver transplantationtranscatheter arterial chemoembolization （TACE）and percutaneous abla－ti... 第94回日本消化器病学会総会＞ IF2-4-V (Plenary presentation) Targeted dual therapy for hepatocellular carcinoma using drug-loaded superparamagnetic nanoparticles Jason Chang（Dept of Gastroenterology and HepatologySingapore General HospitalSingapore^1） Background ： Superparamagnetic iron-oxide nanoparticles （NP） are non-magnetic unless external mag-netic field （MF） is applied． Poly-N-isopropylacrylamide （PNIPA） is a thermosensitive polymer that shri... 第94回日本消化器病学会総会＞

セッション

検索結果は5件です。

IF2-4-I (Keynote lecture) Image-guided percutaneous ablation therapies for hepatocellular carcinoma: Shuichiro Shiina（University of TokyoTokyoJapan）
Image-guided percutaneous ablation therapies have been playing important roles in the treatment of he-patocellular carcinoma （HCC）since they are potentially curativeminimally invasiveand easily re-per...
第94回日本消化器病学会総会＞
IF2-4-II (Keynote lecture) Resection and Transplantation for HCC: Jacques Belghiti（Hepatobiliopancreatic and Liver Transplantation DepartmentHospital BeaujonClichyFrance）
Over the past 10 yearsthere has been considerable progress in the surgical treatment of HCC including adramatic improvement of surgical resections． The high rate of recurrenceespecially in patients wi...
第94回日本消化器病学会総会＞
IF2-4-III (Keynote lecture) Molecular Targeted Therapy for Hepatocellular Carcinoma: Melanie B.Thomas（The University of Texas MD Anderson Cancer CenterHoustonUSA）
Until recently there has been no published evidence that systemic chemotherapy improves overall sur-vival in any subset of HCC patients． HCC are clinically chemotherapy-resistance tumoursand this obse...
第94回日本消化器病学会総会＞
IF2-4-IV (Plenary presentation) Treatment Strategy of Hepatocellular Carcinoma: Ryosuke Tateishi（Department of GastroenterologyThe University of Tokyo Hospital）
Current options fbr the treatment of hepatocellular carcinoma（HCC）consist of surgical resectionor－thotropic liver transplantationtranscatheter arterial chemoembolization （TACE）and percutaneous abla－ti...
第94回日本消化器病学会総会＞
IF2-4-V (Plenary presentation) Targeted dual therapy for hepatocellular carcinoma using drug-loaded superparamagnetic nanoparticles: Jason Chang（Dept of Gastroenterology and HepatologySingapore General HospitalSingapore^1）
Background ： Superparamagnetic iron-oxide nanoparticles （NP） are non-magnetic unless external mag-netic field （MF） is applied． Poly-N-isopropylacrylamide （PNIPA） is a thermosensitive polymer that shri...
第94回日本消化器病学会総会＞